CASTLEMANS DISEASE AND INTERLEUKIN-6

被引:7
作者
YABUHARA, A
KOMIYAMA, A
机构
[1] Department of Pediatrics, Shinshu University School of Medicine, Matsumoto
关键词
Castleman's disease; Interleukin; 6;
D O I
10.3109/10428199009069289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Castleman's disease is a rare condition characterized by benign hyperplastic lymph nodes. Based on the morphological features, it has been divided into hyaline-vascular, plasma cell and intermediate types. The latter two types are frequently associated with a wide variety of clinical pictures such as fever, anemia with hypotransferrinemia, hyperimmunoglobulinemia and an increase in the concentration of C-reactive protein (CRP). Although immunological disturbances have been suggested to play important roles in the pathophysiology of Castleman's disease, the precise mechanisms for the generation of its clinical pictures are still unsettled. In this respect, we have reported a pediatric case with spontaneous production of high levels of B cell differentiation factor (BCDF) activity by the hyperplastic lymph node, and we demonstrated here the strong expression of interleukin 6 (IL-6) gene in the lymph node cells. On the other hand, recent studies have revealed that IL-6 is a multifunctional cytokine; IL-6 not only induces the immunoglobulin production but also induces the acute phase reaction, and functions as an endogeneous pyrogen. In the acute phase reaction, IL-6 may induce an increase in CRP concentration and hypotransferrinemia. These studies indicate that the overproduction of IL-6 by the hyperplastic lymph node may be closely related to the pathophysiology of Castleman's disease. Therefore, it is considered that this disease is a "disorder of IL-6 production" © 1990 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:369 / 380
页数:12
相关论文
共 114 条
  • [1] Castleman B., Towne V.W., Case records of the Massachusetts General Hospital: Weekly clinicopathological exercises. Case 40011, N. Engl. J. Med, 250, pp. 26-30, (1954)
  • [2] Anagnostou D., Harrison C.V., Angiofollicular lymph node hyperplasia (Castleman), J. Clin. Pathol, 25, pp. 306-311, (1972)
  • [3] Nagai K., Sato I., Shimoyama N., Pathohistological and immunohistochemical studies on Castleman's disease of the lymph node, Virchows Arch.[A], 409, pp. 287-297, (1986)
  • [4] Keller A.R., Hochholzer L., Castleman B., Hyalinevascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations, Cancer, 29, pp. 670-683, (1972)
  • [5] Flendrig J.A., Clark R.L., Cumley R.W., Benign giant lymphoma: Clinicopathologic correlation study, Yearbook of Cancer, pp. 296-299, (1970)
  • [6] Diamond L.W., Braylan R.C., Immunological markers and DNA content in a case of giant lymph node hyperplasia (Castleman's disease), Cancer, 46, pp. 730-735, (1980)
  • [7] Lattes R., Pachter M.R., Benign lymphoid masses of probable hamartomatous nature: Analysis of 12 cases, Cancer, 15, pp. 197-214, (1962)
  • [8] Tung K.S.K., Mc Cormack L.J., Angiomatous lymphoid hamartoma: Report of five cases with a review of the literature, Cancer, 20, pp. 525-536, (1967)
  • [9] Zettergren L., Probably neoplastic proliferation of lymphoid tissue (follicular lympho-reticuloma): Report of four cases with a survey of literature, Acta. Path. Microbiol. Scand, 51, pp. 113-126, (1961)
  • [10] Fisher E.R., Sieracki J.C., Goldenberg D.M., Identity and nature of isolated lymphoid tumors (so-called nodal hyperplasia, hamartoma, and angiomatous hamartoma) as revealed by histological, electron microscopic, and heterotransplantation studies, Cancer, 25, pp. 1286-1300, (1970)